Veraxa Biotech AG - Post de-SPAC (VRXA) Executive Compensation
Veraxa Biotech AG - Post de-SPAC (VRXA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VRXA
CIK: 2079109
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grassi & Co., CPAs, P.C.
Auditor SinceSince 6/30/2025 12:00:00 AM
Lead Engagement PartnerJames Mclntosh
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-10-15 | 6-K | 0001829126-26-011185 | View SEC Doc Filr Page |
| 3 | 2026-09-14 | 2026-09-01 | FORM 3 | 0001829126-26-010085 | View SEC Doc Filr Page |
| 424B3 | 2026-09-04 | — | 424B3 | 0001829126-26-009754 | View SEC Doc Filr Page |
| 424B3 | 2026-09-04 | — | 424B3 | 0001829126-26-009753 | View SEC Doc Filr Page |
| 6-K | 2026-09-04 | 2026-09-04 | 6-K | 0001829126-26-009752 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | FORM 4 | 0001829126-26-009544 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | FORM 4 | 0001829126-26-009543 | View SEC Doc Filr Page |
| 6-K | 2026-08-24 | 2026-08-24 | 6-K | 0001829126-26-009237 | View SEC Doc Filr Page |
| 3 | 2026-08-20 | 2026-07-10 | FORM 3 | 0001829126-26-009154 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001167557-26-000206 | View SEC Doc Filr Page |
| 424B5 | 2026-08-10 | — | 424B5 | 0001829126-26-008548 | View SEC Doc Filr Page |
| 424B5 | 2026-08-10 | — | 424B5 | 0001829126-26-008547 | View SEC Doc Filr Page |
| EFFECT | 2026-08-06 | — | EFFECT Filing | 9999999995-26-002591 | View SEC Doc Filr Page |
| EFFECT | 2026-08-06 | — | EFFECT Filing | 9999999995-26-002577 | View SEC Doc Filr Page |
| F-1/A | 2026-08-05 | — | F-1/A | 0001829126-26-008400 | View SEC Doc Filr Page |
| F-1/A | 2026-08-05 | — | F-1/A | 0001829126-26-008399 | View SEC Doc Filr Page |
| F-1 | 2026-07-31 | — | F-1 | 0001829126-26-008247 | View SEC Doc Filr Page |
| F-1 | 2026-07-31 | — | F-1 | 0001829126-26-008246 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | 6-K | 0001829126-26-008238 | View SEC Doc Filr Page |
| 6-K | 2026-07-27 | 2026-07-27 | 6-K | 0001829126-26-007881 | View SEC Doc Filr Page |
| 6-K | 2026-07-27 | 2026-07-27 | 6-K | 0001829126-26-007854 | View SEC Doc Filr Page |
| 6-K | 2026-06-18 | 2026-06-18 | 6-K | 0001829126-26-006695 | View SEC Doc Filr Page |
| 20-F | 2026-06-16 | 2025-12-31 | 20-F | 0001829126-26-006546 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-16 | — | SCHEDULE 13D Filing | 0002134715-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-16 | — | SCHEDULE 13D Filing | 0002134838-26-000001 | View SEC Doc Filr Page |